PinkDx Announces Second Close of Upsized Series A Financing with New Investors Blue Venture Fund, Sandbox Clinical Ventures and BEVC | PR Newswire [Video]

Brings total raised in round to $45 million

Funding will advance company’s first test addressing unmet diagnostic needs in gynecologic cancer

, /PRNewswire/ — PinkDx, Inc., an early-stage company focused on positively impacting the health of women throughout their life journey, today announced that it has completed a second close of its previously announced Series A financing, raising an additional $5 million, including from new investors Blue Venture Fund, Sandbox Clinical Ventures and BEVC. This brings the total raised in the upsized round to $45 million. The funding will help PinkDx further advance its first test, which is intended to clarify diagnosis for women presenting with a potential gynecologic cancer.

The Series A financing was led by Catalio Capital Management, LP, The Production Board and Mountain Group Partners, with participation by Byers Capital, Mayo Clinic and new investors Blue Venture Fund, Sandbox Clinical Ventures and BEVC, founded by Risa Stack, Ph.D., and other industry-investment veterans.

“We are …